首页> 外文期刊>Diabetes, metabolic syndrome and obesity: targets and therapy >Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis
【24h】

Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis

机译:基于血酮水平和主要社会诊断标准的糖尿病酮症酸中毒的各种表现形式的表征:评估糖尿病酮症酸中毒的新观点

获取原文
       

摘要

Aim: We aimed to evaluate the clinical utility of blood ketone measurement and to test the performance of the diagnostic criteria for diabetic ketoacidosis (DKA) issued by the American Diabetes Association, the Joint British Diabetes Societies, and the American Association of Clinical Endocrinologists and the American College of Endocrinology. Methods: This retrospective analysis included 278 patients with suspected DKA who were hospitalized at 4 university hospitals and aged ≥16?years with a blood glucose level of 200?mg/dL and a blood ketone level of ≥1.0?mmol/L as well as other biochemical data. The patients were categorized into four subgroups (ketosis, typical DKA, atypical DKA, and DKA + lactic acidosis). Atypical DKA in each analysis was defined by our supplementary criteria if the biochemical data did not meet each set of diagnostic criteria from the aforementioned societies. Results: Blood ketone levels in patients with diabetic ketosis and those with DKA varied widely, 1.05–5.13?mmol/L and 1.02–15.9?mmol/L, respectively. Additionally, there were significant discrepancies between the guidelines in the diagnosis of DKA. Thus, the proportion of patients with atypical DKA ranged from 16.5% to 42.4%. Notably, the in-hospital mortality was comparable between patients with typical and atypical DKA, with a very high mortality in patients with DKA + lactic acidosis (blood lactate 5?mmol/L). Conclusions: Our results showed that considering variable presentations of DKA, blood ketone data need to be interpreted cautiously along with other biochemical data and suggested that a new system is required to better characterize DKA.
机译:目的:我们旨在评估血酮测定的临床效用,并测试由美国糖尿病学会,联合英国糖尿病学会,美国临床内分泌学家学会和美国内分泌学院。方法:这项回顾性分析包括278例在4所大学医院住院且年龄≥16岁的可疑DKA患者,其血糖水平> 200?mg / dL,血酮水平也≥1.0?mmol / L。以及其他生化数据。将患者分为四个亚组(酮症,典型DKA,非典型DKA和DKA +乳酸性酸中毒)。如果生化数据不符合上述社会的每套诊断标准,则我们的补充标准定义了每次分析中的非典型DKA。结果:糖尿病酮症患者和DKA患者的血酮水平差异很大,分别为1.05–5.13?mmol / L和1.02–15.9?mmol / L。此外,在DKA诊断中,指南之间存在显着差异。因此,非典型DKA患者的比例为16.5%至42.4%。值得注意的是,典型和非典型DKA患者的院内死亡率相当,而DKA +乳酸性酸中毒(血乳酸> 5?mmol / L)的患者死亡率很高。结论:我们的结果表明,考虑到DKA的可变表达,需要谨慎地解释血酮数据以及其他生化数据,并建议需要一种新的系统来更好地表征DKA。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号